The FMR2 gene, FRAXE and non-specific X-linked mental retardation: clinical and molecular aspects
1Department of Cytogenetics and Molecular Genetics, Centre for Medical Genetics, Women's and Children's Hospital, North Adelaide, SA, Australia. jgecz@mad.adelaide.edu.au
Abstract:
FRAXE fragile site associated mental retardation remains unique among X-linked mental retardation phenotypes due to its very mild to borderline nature (50< IQ< 85). It is the most prevalent form of non-specific X-linked mental retardation so far delineated, with an estimated incidence of at least 1/50-100,000 males, and with more than 50 families known worldwide. The FRAXE site is within, or immediately adjacent to, the 5' untranslated region of the FMR2 gene. Hyperexpansion of the FRAXE CCG repeat silences transcription of the gene. The structure of FMR2 has been characterized, but its function remains unknown. Gene localizations for numerous (> 75) large families with non-specific X-linked mental retardation (MRX) have been determined so far. Recently the molecular basis for some of them has been unravelled by identification of the responsible genes, which participate in complex common signalling pathways. This review summarises the new data on FRAXE associated mental retardation and the FMR2 gene in the light of the recent discoveries of new genes responsible for other forms of non-specific X-linked mental retardation.
Insights
FRAXE fragile site mental retardation, the most common X-linked form, is linked to the FMR2 gene. Repeat expansions in FRAXE silence FMR2, causing mild to borderline intellectual disability.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- FRAXE fragile site mental retardation is a prevalent X-linked condition with mild to borderline intellectual disability (IQ 50-85).
- It is the most common form of non-specific X-linked mental retardation, affecting at least 1 in 50,000-100,000 males globally.
- The FRAXE site is located near the FMR2 gene, and repeat expansions are known to silence its transcription.
Purpose of the Study:
- To review current data on FRAXE-associated mental retardation and the FMR2 gene.
- To contextualize these findings within recent discoveries of genes responsible for other non-specific X-linked mental retardation forms.
- To explore the molecular mechanisms underlying FRAXE fragile site mental retardation.
Main Methods:
- Literature review of genetic and molecular studies on FRAXE and FMR2.
- Analysis of existing data on the prevalence and genetic basis of X-linked mental retardation.
- Comparison of FMR2 gene characteristics with newly identified genes for non-specific X-linked mental retardation.
Main Results:
- Hyperexpansion of the FRAXE CCG repeat leads to FMR2 gene transcriptional silencing.
- The FMR2 gene's structure is known, but its function remains elusive.
- Recent advances have identified genes involved in common signaling pathways for other forms of non-specific X-linked mental retardation.
Conclusions:
- FRAXE-associated mental retardation is primarily caused by FMR2 gene silencing due to CCG repeat expansions.
- Understanding FMR2's function is crucial for elucidating the pathophysiology of FRAXE mental retardation.
- Continued research into X-linked mental retardation genes may reveal shared molecular pathways.
More Related Videos
Related Concept Videos
Sex-linked Disorders
X-linked Traits
Pedigree Analysis
X-Inactivation


